Search details
1.
[Efforts of Lung Cancer Oncologists in the"With COVID-19"Era].
Gan To Kagaku Ryoho
; 48(8): 1007-1011, 2021 Aug.
Article
in Japanese
| MEDLINE | ID: mdl-34404066
2.
Reproducibility of the T-SPOT.TB test for screening Mycobacterium tuberculosis infection in Japan.
J Infect Chemother
; 26(2): 194-198, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31495568
3.
Combination treatment options for small-cell lung cancer.
Lancet Oncol
; 22(3): e83, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33662291
4.
Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis.
Cancer Med
; 13(7): e7162, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38572952
5.
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer.
JAMA Oncol
; 10(4): 439-447, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38451530
6.
Clinically-meaningful improvements in therapy for unresectable NSCLC.
Expert Rev Anticancer Ther
; 22(9): 927-937, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35838638
7.
Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy.
Ther Adv Med Oncol
; 14: 17588359211065152, 2022.
Article
in English
| MEDLINE | ID: mdl-35126682
8.
The best regimens for chemo-naïve incurable non-squamous non-small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1-49%: a network meta-analysis.
Transl Lung Cancer Res
; 10(8): 3550-3566, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34584856
9.
Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis.
Thorac Cancer
; 12(7): 1096-1105, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33565276
10.
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer.
Thorac Cancer
; 12(11): 1726-1734, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33943031
11.
Class A CpG oligodeoxynucleotide inhibits IFN-γ-induced signaling and apoptosis in lung cancer.
Thorac Cancer
; 11(4): 983-992, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32067413
12.
Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan.
Tuberculosis (Edinb)
; 125: 101992, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32957053
13.
Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor.
Anticancer Res
; 40(7): 3889-3896, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32620629
14.
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancer.
Thorac Cancer
; 11(10): 2975-2982, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32893980
15.
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial.
Thorac Cancer
; 11(8): 2125-2129, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32495514
16.
Non-small cell lung cancer with mesenchymal-epithelial transition gene exon 14 skipping mutation treated with crizotinib.
Respirol Case Rep
; 7(7): e00453, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31312453
Results
1 -
16
de 16
1
Next >
>>